Literature DB >> 1159925

Fate of 90 children with ileal conduit urinary diversion a decade later: analysis of complications, pyelography, renal function and bacteriology.

S R Shapiro, R Lebowitz, A H Colodny.   

Abstract

A study of the long-term results of ileal conduit urinary diversion for non-malignant disease in 90 children has shown that there were 75 survivors after 10 to 16 years. Stomal stenosis and ureteroileal or other intrinsic obstructions requiring ileal loop revisions occurred frequently and as late as 13 years postoperatively. Of 144 renal units 76 per cent improved or remained stable and 69.3 per cent of normal kidneys remained normal after more than a decade of urinary diversion. In order to obtain these results close lifetime followup and aggressive loop revisions have been required. Urine cultures were consistently negative in 70.5 per cent of all patients. Good results were obtained in terms of preservation of renal function in all categories. Creatinine clearance remained in the normal range after 10 years if the excretory urogram remained normal. Ileal conduit urinary diversion remains a major surgical undertaking but it also remains the standard of urinary diversion against which all other methods must be judged. The results in terms of renal preservation are impressive but so too are the significant number of long-term complications. Any other method of diversion (such as the sigmoid conduit) that can improve upon these results will be welcomed. All children with ileal conduit urinary diversion for reasons other than a neurogenic bladder must be considered candidates for urinary reconstruction.

Entities:  

Mesh:

Year:  1975        PMID: 1159925     DOI: 10.1016/s0022-5347(17)67010-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  A "novel" surgical approach to ureteroileal anastomosis in patients with bricker urinary diversion.

Authors:  F Sofras; D Kontothanassis; D Kouroupakis
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  [Urinary diversion in childhood: special attention to the long-term consequences and complications].

Authors:  R Stein; A Schröder; J W Thüroff
Journal:  Urologe A       Date:  2011-05       Impact factor: 0.639

3.  [Surgical urinary diversion in children from war and crisis areas-20-year experience report].

Authors:  J Kranz; M Dück; C Steffens; B Reisch; J Steffens
Journal:  Urologe A       Date:  2018-10       Impact factor: 0.639

Review 4.  The management of the neuropathic bladder in childhood.

Authors:  M Borzyskowski; A R Mundy
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

5.  Urinary tract re-functionalization after long-term diversion. A 20-year experience with 177 patients.

Authors:  W H Hendren
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

6.  Urinary diversion.

Authors:  R Tscoll
Journal:  Urol Res       Date:  1978

7.  Urinary diversion in children and adolescents with neurogenic bladder: the Mainz experience. Part III: Colonic conduit.

Authors:  Raimund Stein; Christoph Wiesner; Rolf Beetz; Manfred Schwarz; Joachim W Thüroff
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

Review 8.  Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach?

Authors:  Angelena B Edwards; Micah Jacobs
Journal:  Curr Urol Rep       Date:  2019-11-16       Impact factor: 3.092

9.  The use of orthotopic neobladders in women undergoing cystectomy for pelvic malignancy.

Authors:  J P Stein; A Stenzl; G D Grossfeld; J A Freeman; D Esrig; S D Boyd; G Bartsch; D G Skinner
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 10.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.